Sonablate HIFU International Registry for PC & BPH Patients
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The SONA FUSION Registry is an observational study designed to evaluate the long-term effectiveness and safety of the Sonablate High-Intensity Focused Ultrasound (HIFU) system. This study focuses on adult men who have been treated for localized prostate cancer, benign prostatic hyperplasia (BPH) with urinary symptoms, or a combination of both conditions. The registry collects real-world medical data from multiple clinics globally to better understand how well the HIFU treatment controls disease and affects urinary and sexual function over a 10- to 20-year period. The study includes two groups of participants: a retrospective group of patients who previously received treatment, and a prospective group of newly treated patients receiving standard clinical care. No experimental interventions are assigned for the purpose of this study. To protect participant privacy, all medical data is completely de-identified and stripped of direct identifiers before being securely transferred to the central coordinating center at Indiana University. The ultimate goal of this research is to improve patient care protocols, advance men's health knowledge, and establish evidence-based guidelines for minimally invasive prostate treatments.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Mężczyzna ze zdiagnozowanym rakiem prostaty na wczesnym etapie lub rozrostem prostaty
- •Przebył już leczenie ultradźwiękami HIFU jako część standardowej opieki medycznej
✗ Disqualifies
- •Prostata zbyt duża (ponad 100 cm³ przy raku lub 80 cm³ przy rozroście) do efektywnego leczenia
- •Rak prostaty z przerzutami do innych narządów
- •Usunięta wcześniej cała prostata chirurgicznie
- •Duże zwapnienia w prostacie utrudniające leczenie
- •Poprzednia operacja odbytnicy lub niemożność przeprowadzenia ultrasonografii przez odbytnicę
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- August 13, 2026
- Sex
- Male only
Therapies / drugs in trial
Locations (1)
Indiana University Medical Center
Indianapolis, United States
Trial contact
Clint D. Bahler, MD, MS
K. Clinton Cary, MD, MPH
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/12/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.